HY-100001-10mg
|
MedChemexpress LLC
|
SKF-96365 (hydrochloride) [CAS 130495-35-1]
|
|
Cancer-Kinase/protease
|
|
HY-100001-100mg
|
MedChemexpress LLC
|
SKF-96365 (hydrochloride) [CAS 130495-35-1]
|
|
Cancer-Kinase/protease
|
|
HY-100001-5mg
|
MedChemexpress LLC
|
SKF-96365 (hydrochloride) [CAS 130495-35-1]
|
|
Cancer-Kinase/protease
|
|
HY-100001-50mg
|
MedChemexpress LLC
|
SKF-96365 (hydrochloride) [CAS 130495-35-1]
|
|
Cancer-Kinase/protease
|
|
HY-100003-10mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
HY-100003-5mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
HY-100003-50mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
HY-100007-100mg
|
MedChemexpress LLC
|
Vonoprazan [CAS 881681-00-1]
|
|
|
|
HY-100007-250mg
|
MedChemexpress LLC
|
Vonoprazan [CAS 881681-00-1]
|
|
|
|
HY-100012-10mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
HY-100012-100mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
HY-100012-25mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
HY-100012-5mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
HY-100012-50mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
HY-100018-10mg
|
MedChemexpress LLC
|
BAY1125976 [CAS 1402608-02-9]
|
|
Cancer-Kinase/protease
|
|
HY-100018-100mg
|
MedChemexpress LLC
|
BAY1125976 [CAS 1402608-02-9]
|
|
Cancer-Kinase/protease
|
|
HY-100018-2mg
|
MedChemexpress LLC
|
BAY1125976 [CAS 1402608-02-9]
|
|
Cancer-Kinase/protease
|
|
HY-100018-5mg
|
MedChemexpress LLC
|
BAY1125976 [CAS 1402608-02-9]
|
|
Cancer-Kinase/protease
|
|
HY-100018-50mg
|
MedChemexpress LLC
|
BAY1125976 [CAS 1402608-02-9]
|
|
Cancer-Kinase/protease
|
|
HY-100028-10mg
|
MedChemexpress LLC
|
AT-130 [CAS 211364-06-6]
|
|
COVID-19-anti-virus
|
|
HY-100028-100mg
|
MedChemexpress LLC
|
AT-130 [CAS 211364-06-6]
|
|
COVID-19-anti-virus
|
|
HY-100028-25mg
|
MedChemexpress LLC
|
AT-130 [CAS 211364-06-6]
|
|
COVID-19-anti-virus
|
|
HY-100028-5mg
|
MedChemexpress LLC
|
AT-130 [CAS 211364-06-6]
|
|
COVID-19-anti-virus
|
|
HY-100028-50mg
|
MedChemexpress LLC
|
AT-130 [CAS 211364-06-6]
|
|
COVID-19-anti-virus
|
|
HY-100033-10mg
|
MedChemexpress LLC
|
NSC5844 [CAS 140926-75-6]
|
|
Cancer-programmed cell death
|
|